Hostname: page-component-78c5997874-lj6df Total loading time: 0 Render date: 2024-11-02T18:40:58.829Z Has data issue: false hasContentIssue false
  • English
  • Français

COVID-19: Neurologic complications and management of neurological symptoms

Published online by Cambridge University Press:  19 July 2023

T. Jupe ,
B. Zenelaj ,
E. Myslimi  and
I. Giannopoulos
T. Jupe*
Affiliation:
Psychiatric Hospital of Attica, Athens, Greece
B. Zenelaj
Affiliation:
National Center for Children Treatment and Rehabilitation
E. Myslimi
Affiliation:
Freelancer Psychiatrist, Tirane, Albania
I. Giannopoulos
Affiliation:
Psychiatric Hospital of Attica, Athens, Greece
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Neurologic complications in patients with COVID-19 are common in hospitalized patients. More than 80 percent of hospitalized patients may have neurologic symptoms at some point during their disease course. Rates vary by geographical location and patient characteristics.

Objectives

Τhe aim of this research is to evaluate the frequency of neurological complications in patients with covid-19.

Methods

A literature review was made using the Pubmed Platform and the keywords: neurological symptoms, Covid-19 pandemic

Results

Myalgias, headache, encephalopathy, and dizziness may be most common, occurring in approximately one-third of patients in China, Europe, and the United States. Neurologic symptoms such as dysgeusia or anosmia may be less common, but accurate ascertainment of symptoms may be limited in patients with severe cognitive or cardiorespiratory dysfunction. Stroke, movement disorders, motor and sensory deficits, ataxia, and seizures appear uncommon

Conclusions

Reports of severe neurological involvement such as encephalitis, encephalopathy, status epilepticus, ischemic and hemorrhagic strokes and severe neuropathies (Guillain-Barré syndrome) in COVID-19 are increasing, which makes this problem particularly relevant to neurological critical care therapy.

Disclosure of Interest

None Declared

Type
Abstract
Information
European Psychiatry , Volume 66 , Special Issue S1: Abstracts of the 31st European Congress of Psychiatry , March 2023 , pp. S810
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2023. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.